Equity

Retained Earnings

Veradermics Retained Earnings decreased by 22.1% to -$150.65M in Q1 2026 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.

Analysis

StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalHigher is better
VolatilityStable
First reportedQ4 2014
Last reportedQ1 2026

How to read this metric

Consistent growth in retained earnings signals a profitable business model that can sustain itself without constant external capital raises.

Detailed definition

The cumulative amount of net income that has been reinvested in the business rather than distributed to shareholders as...

Peer comparison

Mature, highly profitable companies like Apple may actually see this decrease if they return more cash to shareholders via buybacks than they earn in net income.

Metric ID: retained_earnings

Historical Data

2 periods
 Q4 '25Q1 '26
Value-$123.42M-$150.65M
QoQ Change-22.1%
Range-$150.65M-$123.42M

Frequently Asked Questions

What is Veradermics 's retained earnings?
Veradermics (MANE) reported retained earnings of -$150.65M in Q1 2026.
What does retained earnings mean?
The total profits the company has kept and reinvested since it started, after paying out any dividends.